7y7z Citations

Molecular basis for substrate recognition and transport of human GABA transporter GAT1.

Nat Struct Mol Biol 30 1012-1022 (2023)
Related entries: 7y7v, 7y7w, 7y7y

Cited: 8 times
EuropePMC logo PMID: 37400655

Abstract

γ-Aminobutyric acid (GABA), an important inhibitory neurotransmitter in the central nervous system, is recycled through specific GABA transporters (GATs). GAT1, which is mainly expressed in the presynaptic terminals of axons, is a potential drug target of neurological disorders due to its essential role in GABA transport. Here we report four cryogenic electron microscopy structures of human GAT1, at resolutions of 2.2-3.2 Å. GAT1 in substrate-free form or in complex with the antiepileptic drug tiagabine exhibits an inward-open conformation. In the presence of GABA or nipecotic acid, inward-occluded structures are captured. The GABA-bound structure reveals an interaction network bridged by hydrogen bonds and ion coordination for GABA recognition. The substrate-free structure unwinds the last helical turn of transmembrane helix TM1a to release sodium ions and substrate. Complemented by structure-guided biochemical analyses, our studies reveal detailed mechanism of GABA recognition and transport, and elucidate mode of action of the inhibitors, nipecotic acid and tiagabine.

Articles citing this publication (8)

  1. Probing binding and occlusion of substrate in the human creatine transporter-1 by computation and mutagenesis. Clarke A, Farr CV, El-Kasaby A, Szöllősi D, Freissmuth M, Sucic S, Stockner T. Protein Sci 33 e4842 (2024)
  2. Cryo-EM structure of ACE2-SIT1 in complex with tiagabine. Bröer A, Hu Z, Kukułowicz J, Yadav A, Zhang T, Dai L, Bajda M, Yan R, Bröer S. J Biol Chem 300 107687 (2024)
  3. Dopamine reuptake and inhibitory mechanisms in human dopamine transporter. Li Y, Wang X, Meng Y, Hu T, Zhao J, Li R, Bai Q, Yuan P, Han J, Hao K, Wei Y, Qiu Y, Li N, Zhao Y. Nature 632 686-694 (2024)
  4. Molecular basis of human noradrenaline transporter reuptake and inhibition. Tan J, Xiao Y, Kong F, Zhang X, Xu H, Zhu A, Liu Y, Lei J, Tian B, Yuan Y, Yan C. Nature 632 921-929 (2024)
  5. Structural Studies of the Taurine Transporter: A Potential Biological Target from the GABA Transporter Subfamily in Cancer Therapy. Stary D, Bajda M. Int J Mol Sci 25 7339 (2024)
  6. Structure of the human dopamine transporter in complex with cocaine. Nielsen JC, Salomon K, Kalenderoglou IE, Bargmeyer S, Pape T, Shahsavar A, Loland CJ. Nature 632 678-685 (2024)
  7. Substrate binding and inhibition mechanism of norepinephrine transporter. Ji W, Miao A, Liang K, Liu J, Qi Y, Zhou Y, Duan X, Sun J, Lai L, Wu JX. Nature 633 473-479 (2024)
  8. Unveiling the crucial role of betaine: modulation of GABA homeostasis via SLC6A1 transporter (GAT1). Bhatt M, Lazzarin E, Alberto-Silva AS, Domingo G, Zerlotti R, Gradisch R, Bazzone A, Sitte HH, Stockner T, Bossi E. Cell Mol Life Sci 81 269 (2024)